1. | ltxguy6100 | |
2. | kkappel7947 | |
3. | drsillinois | |
4. | mrskellydaniels | |
5. | cfpalombo |
1. | ltxguy6100 | |
2. | kkappel7947 | |
3. | drsillinois | |
4. | mrskellydaniels | |
5. | cfpalombo |
1. | bigbooter16 04/05/2018 Barclays cuts price target to $38 from $41 |
2. | ltxguy6100 03/02/2018 Neofluidics Announces Collaboration with Pfizer Inc. |
3. | ltxguy6100 04/10/2018 Data Monitoring Committee for the Phase 3 ATLAS trial evaluating INLYTA as adjuvant therapy for patients at h… |
4. | kkappel7947 02/12/2018 FDA accepted and granted Priority Review |
5. | kkappel7947 01/24/2018 Wow News??? - BMO Capital sets PT at $39... a whole $2 |
6. | jasonbennett387 07/09/2018 President Trump tweets criticism about Pfizers drug price increases |
7. | jasonbennett387 02/22/2018 Merck KGaA & and Pfizer receive Health Canada approval |
8. | kkappel7947 01/30/2018 Sees FY18 $2.90-3.00 vs $2.78 |
9. | kkappel7947 01/25/2018 Johnson & Johnson has pulled out of the race to buy Pfizer's consumer health business, leaving GlaxoSmithKli… |
10. | ltxguy6100 01/26/2018 European regulators approved Pfizer and Merck's diabetes drug Steglatro |